This Amedeo Smart survey is supported by Pfizer Oncology.
AmedeoMalignant Melanoma |
|
Free Subscription
Oncogene |
- September 2025
- LEE YK, Heo HH, Park UH, Youn H, et al
Tumor antigen PRAME promotes melanoma growth by inactivating p53 through the SIRT1-DBC1 axis.
Oncogene. 2025 Sep 8. doi: 10.1038/s41388-025-03565.
>> Share
August 2025 - BACCHIOCCHI A, Mak M, Khan ZM, Gong X, et al
LZTR1 is a melanoma oncogene that promotes invasion and suppresses apoptosis.
Oncogene. 2025 Aug 30. doi: 10.1038/s41388-025-03538.
>> Share
- HUANG S, Deng W, Wang P, Yan Y, et al
Retraction Note: Fermitin family member 2 promotes melanoma progression by enhancing the binding of p-alpha-Pix to Rac1 to activate the MAPK pathway.
Oncogene. 2025 Aug 5. doi: 10.1038/s41388-025-03524.
>> Share
July 2025 - MANTOVANI G, Bondioni S, Lania AG, Rodolfo M, et al
Retraction Note: High expression of PKA regulatory subunit 1A protein is related to proliferation of human melanoma cells.
Oncogene. 2025 Jul 28. doi: 10.1038/s41388-025-03509.
>> Share
June 2025 - JIANG CC, Croft A, Tseng H-, Guo ST, et al
Correction: Repression of microRNA-768-3p by MEK/ERK signalling contributes to enhanced mRNA translation in human melanoma.
Oncogene. 2025 Jun 10. doi: 10.1038/s41388-025-03442.
>> Share
- MCGRAIL K, Granado-Martinez P, Orsenigo R, Caratu G, et al
Transcriptional reprogramming triggered by neonatal UV radiation or Lkb1 loss prevents BRAF(V600E)-induced growth arrest in melanocytes.
Oncogene. 2025;44:1592-1608.
>> Share
May 2025 - DONG L, Jiang CC, Thorne RF, Croft A, et al
Editorial Expression of Concern: Ets-1 mediates upregulation of Mcl-1 downstream of XBP-1 in human melanoma cells upon ER stress.
Oncogene. 2025 May 8. doi: 10.1038/s41388-025-03436.
>> Share
March 2025 - GREINER D, Xue Q, Waddell TQ, Kurudza E, et al
Human CSPG4-targeting CAR-macrophages inhibit melanoma growth.
Oncogene. 2025 Mar 13. doi: 10.1038/s41388-025-03332.
>> Share
November 2024 - WHABY M, Ketavarapu G, Koide A, Mazzei M, et al
Inhibition and degradation of NRAS with a pan-NRAS monobody.
Oncogene. 2024;43:3489-3497.
>> Share
September 2024 - WORRALL C, Suleymanova N, Crudden C, Drakensjo IT, et al
Correction: Unbalancing p53/Mdm2/IGF-1R axis by Mdm2 activation restrains the IGF-1-dependent invasive phenotype of skin melanoma.
Oncogene. 2024 Sep 9. doi: 10.1038/s41388-024-03146.
>> Share
April 2024 - REGER DE MOURA C, Louveau B, Jouenne F, Vilquin P, et al
Inactivation of kindlin-3 increases human melanoma aggressiveness through the collagen-activated tyrosine kinase receptor DDR1.
Oncogene. 2024 Apr 3. doi: 10.1038/s41388-024-03014.
>> Share
March 2024 - DURAND S, Tang Y, Pommier RM, Benboubker V, et al
ZEB1 controls a lineage-specific transcriptional program essential for melanoma cell state transitions.
Oncogene. 2024 Mar 22. doi: 10.1038/s41388-024-03010.
>> Share
February 2024 - XIAO Y, Zhou L, Andl T, Zhang Y, et al
YAP1 controls the N-cadherin-mediated tumor-stroma interaction in melanoma progression.
Oncogene. 2024 Feb 2. doi: 10.1038/s41388-024-02953.
>> Share
- JESSEN M, Gertzmann D, Liss F, Zenk F, et al
Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers.
Oncogene. 2024;43:578-593.
>> Share
January 2024 - CANNON AC, Budagyan K, Uribe-Alvarez C, Kurimchak AM, et al
Unique vulnerability of RAC1-mutant melanoma to combined inhibition of CDK9 and immune checkpoints.
Oncogene. 2024 Jan 19. doi: 10.1038/s41388-024-02947.
>> Share
December 2023 - HAN S, Zhang M, Qu X, Wu Z, et al
SOX10 deficiency-mediated LAMB3 upregulation determines the invasiveness of MAPKi-resistant melanoma.
Oncogene. 2023 Dec 15. doi: 10.1038/s41388-023-02917.
>> Share
- JAGIRDAR K, Portuallo ME, Wei M, Wilhide M, et al
ERK hyperactivation serves as a unified mechanism of escape in intrinsic and acquired CDK4/6 inhibitor resistance in acral lentiginous melanoma.
Oncogene. 2023 Dec 8. doi: 10.1038/s41388-023-02900.
>> Share
November 2023 - KURTENBACH S, Sanchez MI, Kuznetsoff J, Rodriguez DA, et al
PRAME induces genomic instability in uveal melanoma.
Oncogene. 2023 Nov 29. doi: 10.1038/s41388-023-02887.
>> Share
September 2023 - LUO Y, Zhu Q, Xiang S, Wang Q, et al
Downregulated circPOKE promotes breast cancer metastasis through activation of the USP10-Snail axis.
Oncogene. 2023 Sep 16. doi: 10.1038/s41388-023-02823.
>> Share
- RICHARDS JR, Shin D, Pryor R, Sorensen LK, et al
Correction: Activation of NFAT by HGF and IGF-1 via ARF6 and its effector ASAP1 promotes uveal melanoma metastasis.
Oncogene. 2023 Sep 8. doi: 10.1038/s41388-023-02828.
>> Share
- SHINZAWA K, Matsumoto S, Sada R, Harada A, et al
GREB1 isoform 4 is specifically transcribed by MITF and required for melanoma proliferation.
Oncogene. 2023 Sep 1. doi: 10.1038/s41388-023-02803.
>> Share
July 2023 - ARUMI-PLANAS M, Rodriguez-Baena FJ, Cabello-Torres F, Gracia F, et al
Microenvironmental Snail1-induced immunosuppression promotes melanoma growth.
Oncogene. 2023 Jul 29. doi: 10.1038/s41388-023-02793.
>> Share
- RICHARDS JR, Shin D, Pryor R, Sorensen LK, et al
Activation of NFAT by HGF and IGF-1 via ARF6 and its effector ASAP1 promotes uveal melanoma metastasis.
Oncogene. 2023 Jul 27. doi: 10.1038/s41388-023-02792.
>> Share
June 2023 - LUO R, Chyr J, Wen J, Wang Y, et al
A novel integrated approach to predicting cancer immunotherapy efficacy.
Oncogene. 2023;42:1913-1925.
>> Share
March 2023 - MALVI P, Reddy DS, Kumar R, Chava S, et al
LIMK2 promotes melanoma tumor growth and metastasis through G3BP1-ESM1 pathway-mediated apoptosis inhibition.
Oncogene. 2023 Mar 16. doi: 10.1038/s41388-023-02658.
>> Share
- KUSER-ABALI G, Zhang Y, Szeto P, Zhao P, et al
UHRF1/UBE2L6/UBR4-mediated ubiquitination regulates EZH2 abundance and thereby melanocytic differentiation phenotypes in melanoma.
Oncogene. 2023 Mar 11. doi: 10.1038/s41388-023-02631.
>> Share
- DING Y, Chen J, Li S, Wren JD, et al
EWI2 and its relatives in Tetraspanin-enriched membrane domains regulate malignancy.
Oncogene. 2023;42:861-868.
>> Share
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016
